Patent directory · USPTO A61K / A61P
Patents matching “Atea Pharmaceuticals, Inc.”
23 pharma patents match "Atea Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 23 pharmaceutical patents matching "Atea Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12226429
Highly active compounds against COVID-19
granted -
US 12084473
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 12006340
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
granted -
US 11975016
2′-substituted-N6-substituted purine nucleotides for RNA virus treatment
granted -
US 11813278
Highly active compounds against COVID-19
granted -
US 11738038
Highly active compounds against COVID-19
granted -
US 11707480
Highly active compounds against COVID-19
granted -
US 11690860
Treatment of HCV infected patients with cirrhosis
granted -
US 10946033
2′-substituted-N6-substituted purine nucleotides for RNA virus treatment
granted -
US 10906928
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
granted -
US 10894804
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
granted -
US 10875885
β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment
granted -
US 10874687
Highly active compounds against COVID-19
granted -
US 10870672
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10870673
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10815266
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10711029
Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
granted -
US 10519186
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
granted -
US 10239911
Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10202412
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
granted -
US 10005811
β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10000523
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 9828410
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted